Ofev - Nindanib - Nintedanib

Keep moving forward with OFEV® (nintedanib) capsules, the only twice-daily prescription medication approved to: treat adults with a lung disease called idiopathic pulmonary fibrosis (IPF). treat adults with a long lasting (chronic) interstitial lung disease in which lung fibrosis continues to worsen (progress). slow the rate of decline in lung function in adults with systemic sclerosis-associated interstitial lung disease (SSc-ILD) (also known as scleroderma-associated ILD). It is not known if OFEV is safe and effective in children.